Local environmental effects on the structure of the prion protein.

Prion diseases are neurodegenerative diseases causally linked to the partial unfolding and subsequent misfolding and aggregation of the prion protein (PrP). While most proteins fold into a single low energy state, PrP can fold into two distinct isoforms. In its innocuous state, denoted as PrPC, the protein has predominantly alpha-helical secondary structure, however, PrPC can misfold into an isoform rich in extended structure capable of forming toxic and infectious aggregates. While prion disease is believed to be a protein-only disease, one not requiring any non-protein elements for propagation, the different environments the protein finds itself in vivo likely influence its ability to misfold and aggregate. In this review we will examine various molecules, covalent modifications and environments PrP faces in vivo and the effect they have on PrP's local environment and, potentially, conformation. Included in this discussion are: (1) pH, (2) carbohydrates, (3) lipid membranes, (4) metal ions, and (5) small molecules.

[1]  F. Cohen,et al.  Copper binding to the prion protein: structural implications of four identical cooperative binding sites. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Friedlander,et al.  Characterization of Detergent-insoluble Complexes Containing the Cellular Prion Protein and Its Scrapie Isoform* , 1997, The Journal of Biological Chemistry.

[3]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Kelly,et al.  The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. , 1996, Biochemistry.

[5]  L. Serpell,et al.  Common core structure of amyloid fibrils by synchrotron X-ray diffraction. , 1997, Journal of molecular biology.

[6]  D. Gajdusek,et al.  Scrapie‐associated precursor proteins , 1990, Neurology.

[7]  S. Prusiner,et al.  Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. , 1990, Biochemistry.

[8]  Christopher M. Dobson,et al.  Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.

[9]  J. Collinge,et al.  Multiple folding pathways for heterologously expressed human prion protein. , 1999, Biochimica et biophysica acta.

[10]  S. Haswell,et al.  Consequences of manganese replacement of copper for prion protein function and proteinase resistance , 2000, The EMBO journal.

[11]  S. Prusiner,et al.  Glycosylation differences between the normal and pathogenic prion protein isoforms. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Harris,et al.  A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. , 1993, The Journal of biological chemistry.

[13]  L. Tibell,et al.  Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: Decreased stability of the apo state , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  H. Sato,et al.  Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent , 1995, Journal of virology.

[15]  A. Aguzzi,et al.  Mice devoid of PrP are resistant to scrapie , 1993, Cell.

[16]  P. Low,et al.  Measurement of endosome pH following folate receptor-mediated endocytosis. , 1996, Biochimica et biophysica acta.

[17]  S. Katamine,et al.  Prion Protein Is Necessary for Latent Learning and Long-Term Memory Retention , 1997, Cellular and Molecular Neurobiology.

[18]  B. Chesebro,et al.  Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells , 1989, Journal of virology.

[19]  S. Hornemann,et al.  NMR structure of the bovine prion protein isolated from healthy calf brains , 2004, EMBO reports.

[20]  Neil R. Cashman,et al.  Prion diseases — close to effective therapy? , 2004, Nature Reviews Drug Discovery.

[21]  J. Mcdermott,et al.  Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. , 1995, Biochemical and biophysical research communications.

[22]  N. Hooper,et al.  Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region , 2001, Current Biology.

[23]  J. Laplanche,et al.  Signal transduction through prion protein. , 2000, Science.

[24]  F. Wieland,et al.  The Membrane Domains Occupied by Glycosylphosphatidylinositol-anchored Prion Protein and Thy-1 Differ in Lipid Composition* , 2004, Journal of Biological Chemistry.

[25]  Chahm An,et al.  Simulations of biomolecules: characterization of the early steps in the pH-induced conformational conversion of the hamster, bovine and human forms of the prion protein , 2002, Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences.

[26]  R. G. Anderson The caveolae membrane system. , 1998, Annual review of biochemistry.

[27]  W. Surewicz,et al.  Membrane Environment Alters the Conformational Structure of the Recombinant Human Prion Protein* , 1999, The Journal of Biological Chemistry.

[28]  Stephen J. DeArmond,et al.  Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques , 1989, Cell.

[29]  F E Cohen,et al.  Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Masters,et al.  Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.

[31]  Peter Critchley,et al.  Binding of prion proteins to lipid membranes. , 2004, Biochemical and biophysical research communications.

[32]  M. Palmer,et al.  Prion protein is necessary for normal synaptic function , 1994, Nature.

[33]  F. Cohen,et al.  Cryptic epitopes in N‐terminally truncated prion protein are exposed in the full‐length molecule: Dependence of conformation on pH , 2001, Proteins.

[34]  L. Hood,et al.  Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. , 1993, Biochemistry.

[35]  R. Wetzel,et al.  Conformational Abs recognizing a generic amyloid fibril epitope , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Righetti,et al.  pH-dependent Prion Protein Conformation in Classical Creutzfeldt-Jakob Disease* , 2001, The Journal of Biological Chemistry.

[37]  D. Harris,et al.  Copper Stimulates Endocytosis of the Prion Protein* , 1998, The Journal of Biological Chemistry.

[38]  S. Prusiner,et al.  A transmembrane form of the prion protein in neurodegenerative disease. , 1998, Science.

[39]  M. Zimmermann,et al.  Emerging therapeutic agents for transmissible spongiform encephalopathies: a review. , 2003, Journal of veterinary pharmacology and therapeutics.

[40]  F. Cohen,et al.  Selective Neuronal Targeting in Prion Disease , 1997, Neuron.

[41]  Christopher E. Jones,et al.  Preferential Cu2+ Coordination by His96 and His111 Induces β-Sheet Formation in the Unstructured Amyloidogenic Region of the Prion Protein* , 2004, Journal of Biological Chemistry.

[42]  R. Glockshuber,et al.  Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein. , 2001, Biophysical journal.

[43]  F. Cohen,et al.  Synthetic Mammalian Prions , 2004, Science.

[44]  D. Harris,et al.  Copper Converts the Cellular Prion Protein into a Protease-resistant Species That Is Distinct from the Scrapie Isoform* , 2001, The Journal of Biological Chemistry.

[45]  G. J. Raymond,et al.  The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. , 1991, The Journal of biological chemistry.

[46]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[47]  Yeu Su,et al.  Acidic pH promotes the formation of toxic fibrils from β-amyloid peptide , 2001, Brain Research.

[48]  B. Caughey,et al.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.

[49]  A. Aguzzi,et al.  No propagation of prions in mice devoid of PrP , 1994, Cell.

[50]  S. Prusiner,et al.  Conformation of PrP(C) on the cell surface as probed by antibodies. , 2003, Journal of molecular biology.

[51]  S. Prusiner,et al.  Properties of scrapie prion protein liposomes. , 1988, The Journal of biological chemistry.

[52]  R. Glockshuber,et al.  Characterization of Recombinant, Membrane-attached Full-length Prion Protein* , 2004, Journal of Biological Chemistry.

[53]  R. Wetzel,et al.  Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta. , 1996, Journal of molecular biology.

[54]  J. Gready,et al.  Molecular dynamics simulation of human prion protein including both N-linked oligosaccharides and the GPI anchor. , 2000, Glycobiology.

[55]  B. Caughey,et al.  Effect of Glycosylphosphatidylinositol Anchor-dependent and -independent Prion Protein Association with Model Raft Membranes on Conversion to the Protease-resistant Isoform* , 2003, The Journal of Biological Chemistry.

[56]  Valerie Daggett,et al.  From conversion to aggregation: protofibril formation of the prion protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. Wisniewski,et al.  The prionoses and other conformational disorders. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[58]  K Wüthrich,et al.  NMR structure of the bovine prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Collinge,et al.  Strain-specific prion-protein conformation determined by metal ions , 1999, Nature Cell Biology.

[60]  J. Collinge,et al.  XAFS study of the high-affinity copper-binding site of human PrP(91-231) and its low-resolution structure in solution. , 2001, Journal of molecular biology.

[61]  Stanley B. Prusiner,et al.  Scrapie prion protein contains a phosphatidylinositol glycolipid , 1987, Cell.

[62]  Eliah Aronoff-Spencer,et al.  Molecular features of the copper binding sites in the octarepeat domain of the prion protein. , 2002, Biochemistry.

[63]  R. Gallily,et al.  Mycoplasma fermentans—Induced Inflammatory Response of Astrocytes: Selective Modulation by Aminoguanidine, Thalidomide, Pentoxifylline and IL-10 , 1999, Inflammation.

[64]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[65]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[66]  F E Cohen,et al.  Mapping the early steps in the pH-induced conformational conversion of the prion protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[67]  B. Chesebro,et al.  Conversion of raft associated prion protein to the protease‐resistant state requires insertion of PrP‐res (PrPSc) into contiguous membranes , 2002, The EMBO journal.

[68]  S. Prusiner,et al.  Scrapie PrP 27-30 is a sialoglycoprotein , 1985, Journal of virology.

[69]  S. Prusiner,et al.  Evidence for synthesis of scrapie prion proteins in the endocytic pathway. , 1992, The Journal of biological chemistry.

[70]  V. Daggett,et al.  Preventing misfolding of the prion protein by trimethylamine N-oxide. , 2004, Biochemistry.

[71]  T. Wisniewski,et al.  Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides , 2000, The Lancet.

[72]  W. Surewicz,et al.  pH-dependent Stability and Conformation of the Recombinant Human Prion Protein PrP(90–231)* , 1997, The Journal of Biological Chemistry.

[73]  L. Hood,et al.  Asparagine-linked glycosylation of the scrapie and cellular prion proteins. , 1989, Archives of biochemistry and biophysics.

[74]  S. Prusiner,et al.  Chemical chaperones interfere with the formation of scrapie prion protein. , 1996, The EMBO journal.

[75]  J. Lakey,et al.  Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. , 1995, Biochemical and biophysical research communications.

[76]  J. Hope,et al.  The abnormal isoform of the prion protein accumulates in late‐endosome‐like organelles in scrapie‐infected mouse brain , 1995, The Journal of pathology.

[77]  H. Takeuchi,et al.  Metal‐dependent α‐helix formation promoted by the glycine‐rich octapeptide region of prion protein , 1996, FEBS letters.

[78]  S. Prusiner,et al.  Biogenesis and Transmembrane Orientation of the Cellular Isoform of the Scrapie Prion Protein , 1987, Molecular and cellular biology.

[79]  D. Westaway,et al.  The cellular prion protein binds copper in vivo , 1997, Nature.

[80]  S. Hornemann,et al.  A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[81]  H. Kretzschmar,et al.  Effects of oxidative stress on prion protein expression in pc12 cells , 1997, International Journal of Developmental Neuroscience.

[82]  N. Cashman,et al.  Acidic pH and Detergents Enhance in Vitro Conversion of Human Brain PrPC to a PrPSc-like Form* , 2002, The Journal of Biological Chemistry.

[83]  T. Pinheiro,et al.  Binding of prion protein to lipid membranes and implications for prion conversion. , 2002, Journal of molecular biology.

[84]  D. Harris,et al.  Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi , 2003, Journal of neurochemistry.

[85]  S. Prusiner,et al.  Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. , 1989, Biochemistry.

[86]  A. Burlingame,et al.  Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. , 1999, Biochemistry.

[87]  S. Prusiner,et al.  Copper coordination in the full-length, recombinant prion protein. , 2003, Biochemistry.

[88]  A. Aguzzi,et al.  Prion protein (PrP) with amino‐proximal deletions restoring susceptibility of PrP knockout mice to scrapie. , 1996, The EMBO journal.

[89]  D. Westaway,et al.  Copper(II)-induced Conformational Changes and Protease Resistance in Recombinant and Cellular PrP , 2000, The Journal of Biological Chemistry.

[90]  Kurt Wüthrich,et al.  Prion protein NMR structures of chickens, turtles, and frogs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[91]  T. Noda,et al.  Impaired Motor Coordination in Mice Lacking Prion Protein , 1998, Cellular and Molecular Neurobiology.

[92]  S. Prusiner,et al.  Unusual topogenic sequence directs prion protein biogenesis. , 1990, Science.

[93]  F. Cohen,et al.  COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[94]  F. Cohen,et al.  Prion protein selectively binds copper(II) ions. , 1998, Biochemistry.

[95]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[96]  V. Daggett,et al.  PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. , 1999, Journal of neuropathology and experimental neurology.

[97]  P E Wright,et al.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[98]  A. Giese,et al.  Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein. , 2005, Biochemical and biophysical research communications.

[99]  S. Prusiner,et al.  Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[100]  R. Bujdoso,et al.  Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR. , 2004, The Biochemical journal.